Credit Suisse’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,236
| Closed | -$194K | – | 3147 |
|
|
2023
Q2 | $194K | Sell |
7,236
-2,937
| -29% | -$78.9K | ﹤0.01% | 3082 |
|
|
2023
Q1 | $594K | Buy |
10,173
+711
| +8% | +$41.5K | ﹤0.01% | 2637 |
|
|
2022
Q4 | $483K | Buy |
9,462
+186
| +2% | +$9.49K | ﹤0.01% | 2784 |
|
|
2022
Q3 | $760K | Buy |
9,276
+30
| +0.3% | +$2.46K | ﹤0.01% | 2496 |
|
|
2022
Q2 | $626K | Buy |
9,246
+35
| +0.4% | +$2.37K | ﹤0.01% | 2685 |
|
|
2022
Q1 | $1.02M | Buy |
9,211
+5,068
| +122% | +$561K | ﹤0.01% | 2516 |
|
|
2021
Q4 | $398K | Sell |
4,143
-1,565
| -27% | -$150K | ﹤0.01% | 3168 |
|
|
2021
Q3 | $498K | Buy |
5,708
+110
| +2% | +$9.6K | ﹤0.01% | 2988 |
|
|
2021
Q2 | $866K | Sell |
5,598
-393
| -7% | -$60.8K | ﹤0.01% | 2727 |
|
|
2021
Q1 | $945K | Sell |
5,991
-8,271
| -58% | -$1.3M | ﹤0.01% | 2610 |
|
|
2020
Q4 | $3.31M | Sell |
14,262
-834
| -6% | -$194K | ﹤0.01% | 1795 |
|
|
2020
Q3 | $3.31M | Sell |
15,096
-520
| -3% | -$114K | ﹤0.01% | 1510 |
|
|
2020
Q2 | $4.44M | Buy |
15,616
+9,603
| +160% | +$2.73M | ﹤0.01% | 1356 |
|
|
2020
Q1 | $1.73M | Sell |
6,013
-1,578
| -21% | -$455K | ﹤0.01% | 1745 |
|
|
2019
Q4 | $2.18M | Buy |
7,591
+4,794
| +171% | +$1.38M | ﹤0.01% | 1978 |
|
|
2019
Q3 | $403K | Sell |
2,797
-3,580
| -56% | -$516K | ﹤0.01% | 2909 |
|
|
2019
Q2 | $572K | Sell |
6,377
-511
| -7% | -$45.8K | ﹤0.01% | 2704 |
|
|
2019
Q1 | $603K | Buy |
6,888
+2,488
| +57% | +$218K | ﹤0.01% | 2676 |
|
|
2018
Q4 | $618K | Buy |
4,400
+1,329
| +43% | +$187K | ﹤0.01% | 2628 |
|
|
2018
Q3 | $784K | Sell |
3,071
-51
| -2% | -$13K | ﹤0.01% | 2582 |
|
|
2018
Q2 | $796K | Buy |
3,122
+49
| +2% | +$12.5K | ﹤0.01% | 2732 |
|
|
2018
Q1 | $619K | Buy |
3,073
+403
| +15% | +$81.2K | ﹤0.01% | 2845 |
|
|
2017
Q4 | $384K | Buy |
2,670
+534
| +25% | +$76.8K | ﹤0.01% | 3049 |
|
|
2017
Q3 | $352K | Buy |
2,136
+1,420
| +198% | +$234K | ﹤0.01% | 3189 |
|
|
2017
Q2 | $97K | Sell |
716
-306
| -30% | -$41.5K | ﹤0.01% | 3332 |
|
|
2017
Q1 | $197K | Sell |
1,022
-169
| -14% | -$32.6K | ﹤0.01% | 3251 |
|
|
2016
Q4 | $168K | Sell |
1,191
-464
| -28% | -$65.5K | ﹤0.01% | 3495 |
|
|
2016
Q3 | $242K | Buy |
1,655
+324
| +24% | +$47.4K | ﹤0.01% | 3402 |
|
|
2016
Q2 | $134K | Buy |
+1,331
| New | +$134K | ﹤0.01% | 3692 |
|
|
2016
Q1 | – | Sell |
-3,172
| Closed | -$630K | – | 3812 |
|
|
2015
Q4 | $630K | Buy |
+3,172
| New | +$630K | ﹤0.01% | 2983 |
|
|
2015
Q3 | – | Sell |
-4,169
| Closed | -$1.7M | – | 4090 |
|
|
2015
Q2 | $1.7M | Buy |
4,169
+2,202
| +112% | +$898K | ﹤0.01% | 2450 |
|
|
2015
Q1 | $903K | Buy |
1,967
+746
| +61% | +$342K | ﹤0.01% | 2808 |
|
|
2014
Q4 | $685K | Buy |
1,221
+700
| +134% | +$393K | ﹤0.01% | 3119 |
|
|
2014
Q3 | $273K | Buy |
521
+116
| +29% | +$60.8K | ﹤0.01% | 3587 |
|
|
2014
Q2 | $282K | Sell |
405
-414
| -51% | -$288K | ﹤0.01% | 3729 |
|
|
2014
Q1 | $380K | Buy |
+819
| New | +$380K | ﹤0.01% | 3552 |
|